PATENT CLAIM ANALYSIS

Application Number: 16159554
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-04
Patent Classification: ["424", "134100"]

Abstract:
Provided herein are B cell maturation agent (BCMA) targeting trispecific proteins comprising a domain binding to CD3, a half-life extension domain, and a domain binding to BCMA. Also provided are pharmaceutical compositions thereof, as well as nucleic acids, recombinant expression vectors and host cells for making such BCMA targeting trispecific proteins. Also disclosed are methods of using the disclosed BCMA targeting trispecific proteins in the prevention, and/or treatment diseases, conditions and disorders.

Claim (Index 6):
The BCMA binding protein of  claim 1 , wherein the first domain, the second domain, and the third domain are independently humanized or human.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 97.0
- Lexical Diversity: 1.56604
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15977968', '15160984', '14805193', '15965738', '15600582']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7585710684571932
- 35 USC 102 Novelty (BERT): 0.549101558135403
- Combined Prediction Score: 0.7376241174250142
- Mean Citation Score: 383.231464
- Max Citation Score: 426.4887
- Similarity Product: 297.9562901330532

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test